90 related articles for article (PubMed ID: 22898202)
1. Downregulation of Pael-R expression in a Parkinson's disease cell model reduces apoptosis.
Zou T; Xiao B; Tang J; Zhang H; Tang X
J Clin Neurosci; 2012 Oct; 19(10):1433-6. PubMed ID: 22898202
[TBL] [Abstract][Full Text] [Related]
2. A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin.
Omura T; Kaneko M; Okuma Y; Orba Y; Nagashima K; Takahashi R; Fujitani N; Matsumura S; Hata A; Kubota K; Murahashi K; Uehara T; Nomura Y
J Neurochem; 2006 Dec; 99(6):1456-69. PubMed ID: 17059562
[TBL] [Abstract][Full Text] [Related]
3. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
Wang HQ; Imai Y; Inoue H; Kataoka A; Iita S; Nukina N; Takahashi R
J Neurochem; 2008 Oct; 107(1):171-85. PubMed ID: 18691389
[TBL] [Abstract][Full Text] [Related]
4. Pael receptor, endoplasmic reticulum stress, and Parkinson's disease.
Takahashi R; Imai Y
J Neurol; 2003 Oct; 250 Suppl 3():III25-9. PubMed ID: 14579121
[TBL] [Abstract][Full Text] [Related]
5. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
6. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
7. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.
Yang Y; Nishimura I; Imai Y; Takahashi R; Lu B
Neuron; 2003 Mar; 37(6):911-24. PubMed ID: 12670421
[TBL] [Abstract][Full Text] [Related]
8. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation.
Kitao Y; Imai Y; Ozawa K; Kataoka A; Ikeda T; Soda M; Nakimawa K; Kiyama H; Stern DM; Hori O; Wakamatsu K; Ito S; Itohara S; Takahashi R; Ogawa S
Hum Mol Genet; 2007 Jan; 16(1):50-60. PubMed ID: 17116640
[TBL] [Abstract][Full Text] [Related]
9. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.
Imai Y; Soda M; Hatakeyama S; Akagi T; Hashikawa T; Nakayama KI; Takahashi R
Mol Cell; 2002 Jul; 10(1):55-67. PubMed ID: 12150907
[TBL] [Abstract][Full Text] [Related]
10. Pael receptor is involved in dopamine metabolism in the nigrostriatal system.
Imai Y; Inoue H; Kataoka A; Hua-Qin W; Masuda M; Ikeda T; Tsukita K; Soda M; Kodama T; Fuwa T; Honda Y; Kaneko S; Matsumoto S; Wakamatsu K; Ito S; Miura M; Aosaki T; Itohara S; Takahashi R
Neurosci Res; 2007 Dec; 59(4):413-25. PubMed ID: 17889953
[TBL] [Abstract][Full Text] [Related]
11. [Neurodegeneration caused by ER stress?--the pathogenetic mechanisms underlying AR-JP].
Takahashi R
Nihon Yakurigaku Zasshi; 2004 Dec; 124(6):375-82. PubMed ID: 15572841
[TBL] [Abstract][Full Text] [Related]
12. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
13. A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses Pael receptor-induced cell death.
Imai Y; Soda M; Murakami T; Shoji M; Abe K; Takahashi R
J Biol Chem; 2003 Dec; 278(51):51901-10. PubMed ID: 14532270
[TBL] [Abstract][Full Text] [Related]
14. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
Korutla L; Furlong HA; Mackler SA
Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
[TBL] [Abstract][Full Text] [Related]
15. The Pael-R gene does not mediate the changes in rotenone-induced Parkinson's disease model cells.
Zou T; Tang X; Huang Z; Xu N; Hu Z
Neural Regen Res; 2014 Feb; 9(4):402-6. PubMed ID: 25206827
[TBL] [Abstract][Full Text] [Related]
16. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson's disease.
Zhang X; Lu L; Liu S; Ye W; Wu J; Zhang X
Int J Biochem Cell Biol; 2013 Feb; 45(2):265-72. PubMed ID: 23201480
[TBL] [Abstract][Full Text] [Related]
18. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
Yasuda T; Mochizuki H
Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
[TBL] [Abstract][Full Text] [Related]
19. Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death.
Sengupta A; Hon T; Zhang L
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):23-30. PubMed ID: 15950757
[TBL] [Abstract][Full Text] [Related]
20. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
